TG Therapeutics Stock Discussion

$TG Therapeutics(TGTX.US)$ good news sure go down these days

$TG Therapeutics(TGTX.US)$ 07:04 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (TGTX) TG THERAPEUTICS Reports Q1 Revenue $63.5M, vs. Street Est of $54.6M

$TG Therapeutics(TGTX.US)$    TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for Briumvi as the Preferred Anti-Cd20 for Relapsing Forms of Multiple Sclerosis   TG Therapeutics Inc - Total Award Amount of Contract Has a Potential Value of $186.8 Mln

$JPMorgan(JPM.US)$ just out - $TG Therapeutics(TGTX.US)$ BUY PT 25 VA contract Unequivocal  win for TGTX on couple fronts 👍 few details still to be worked out but looks like 40 million a year new durable revenue stream for $TG Therapeutics(TGTX.US)$

$TG Therapeutics(TGTX.US)$ short interest still trending up - $Viking Therapeutics(VKTX.US)$ - short interest down some

$TG Therapeutics(TGTX.US)$ skyrocketed 28% after the biotech company reported better-than-expected net loss for fourth quarter and exceeded both the quarterly revenue and the outlook for 2024.
The company said fourth quarter loss narrowed to 9 cents a share from 39 cents a year earlier. That's smaller than the 11 cents expected by analysts polled by Capital IQ, according to MT Newswires.
Revenue for the three months ende...